cis-Diethyl Stilbestrol

Catalog No.: 
ACFQBO325
CAS No.: 
22610-99-7
Molecular Formula: 
C18H20O2
Molecular Weight: 
268.36
cis-Diethyl Stilbestrol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$124.00InquiryInquiry
100g98%$486.00InquiryInquiry
500g98%$2381.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namecis-Diethyl Stilbestrol
IUPAC Name(Z)-4,4'-(hex-3-ene-3,4-diyl)diphenol
MDL No.MFCD00870590
Molecular FormulaC18H20O2
Molecular Weight268.36
SMILESOC1=CC=C(C=C1)/C(CC)=C(CC)\C2=CC=C(O)C=C2
InChI KeyRGLYKWWBQGJZGM-ZCXUNETKSA-N
Synonym4-[(Z)-4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol | Stilbestrol;DES | 4-[(1Z)-1-ethyl-2-(4-hydroxyphenyl)but-1-enyl]phenol | 4-[(3Z)-4-(4-HYDROXYPHENYL)HEX-3-EN-3-YL]PHENOL | Phenol, 4,4'-(1,2-diethyl-1,2-ethenediyl)bis- | AI3-17297 | DTXSID501314114 | E8544
CAS No.22610-99-7
PubChem CID688057

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACFQBO325 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLXCN463 route compound structure diagram
    ACLXCN46370-70-2In Stock
  2. Plus
  3. ACLXCN463 route compound structure diagram
    ACLXCN46370-70-2In Stock
  4. Then
  5. ACFQBO325 route product structure diagram
    ACFQBO32522610-99-7
Inquiry

2. ACFQBO325 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFQBO325 route product structure diagram
    ACFQBO32522610-99-7
Inquiry

3. ACFQBO325 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFQBO325 route product structure diagram
    ACFQBO32522610-99-7
Inquiry

Comments (0)